Abbott's rapid coronavirus test misses nearly half of positive cases, study finds | TheHill

A rapid coronavirus diagnostic test manufactured by Abbott may miss nearly half of all positive infections, according to a pre-published study from New York University. The analysis of Abbott's ID NOW system, which has not been peer-reviewed, found the test to be 'unacceptable' in a clinical setting. But Abbott said it's not clear if the researchers used the samples correctly. A spokesperson said the company's own rate of false negatives that it has shared with the Food and Drug Administration (FDA) is .02 percent.